Short answer
Teladoc Health, Inc. (TDOC) filed its Q3 2026 10-Q quarterly report on Oct 29, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $605M (down 3.4% year over year) with net income of −$27M.
Q3 2026 key financials · XBRL
- Revenue
- $605M
- −3.4% YoY · −0.3% QoQ
- Net income
- −$27M
- +45.6% YoY · +30.8% QoQ
- Operating margin
- -4.6%
- EPS (diluted)
- −$0.15
- +46.4% YoY · +28.6% QoQ
Source: XBRL data from the Teladoc Health, Inc. (TDOC) Q3 2026 10-Q on SEC EDGAR. USD.
Teladoc Health, Inc. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 revenue $605.1M, down $21.3M or 3% YoY, driven by BetterHelp decline
- Integrated Care best performer: revenue $398.5M, up 2%; Adjusted EBITDA margin 18.8% vs 17.0%
- BetterHelp weakest segment: revenue $206.6M, down 13%; Adjusted EBITDA margin 2.2% vs 1.6%
- Cash $849.9M; nine-month operating cash flow $180.6M vs $206.6M, free cash flow $85.4M
- 2026 BetterHelp outlook reduced, with fewer users and lower revenue expected as cash-pay declines outpace insurance growth
Risk Factors
- New litigation risk: derivative complaints consolidated in 2026, with Kimbrew filed September 17, 2026 alleging insider trading and misappropriation
- Regulatory and compliance risk: BetterHelp privacy, advertising, contract, and tort lawsuits tied to the FTC’s July 2023 consent order
- Competitive and market risk: BetterHelp revenue declined to $206.6 million from $236.9 million, while advertising fell to $98.8 million from $134.6 million
- Financial risk: $1.0 billion of 1.25% convertible notes classified current, maturing June 1, 2027
- Operational risk: chronic-condition brand transition increased amortization expense by $23.0 million through September 30, 2026
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Teladoc Health, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.